Related Experiment Videos
[Efficacy of hepatitis B preventive vaccination]
F Hofmann1, N Kralj, H M Hasselhorn
1Bergische Universität/Gesamthochschule Wuppertal, Lehrstuhl.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|August 1, 1997
Summary
Hepatitis B vaccination provides long-term protection for healthcare workers. Studies show children vaccinated per recommendations achieve over 99% protection, with sustained antibody levels for at least a decade.
Area of Science:
- Immunology
- Vaccinology
- Occupational Health
Context:
- Healthcare workers face elevated hepatitis B virus (HBV) exposure risks.
- A study assessed hepatitis B vaccination efficacy and protection duration among 5035 individuals at Freiburg university hospital.
Purpose:
- To evaluate the long-term immunogenicity and protective efficacy of hepatitis B vaccination in a large cohort.
- To identify factors influencing antibody response and duration of protection post-vaccination.
Summary:
- Post-vaccination anti-HBs levels were higher in women, younger individuals, those with BMI < 25, and non-smokers.
- Non-response and low-response rates were low (2% female, 1.5% male non-responders; 4.8% female, 7.1% male low responders).
- At least 50% of vaccinees maintained anti-HBs > 100 IU/l ten years post-immunization, indicating durable protection.
Impact:
- Confirms that childhood hepatitis B vaccination, following German and WHO guidelines, ensures robust and lasting protection (>99% achieving protective antibody levels).
- Highlights the importance of vaccination programs for healthcare worker safety and public health.
- Provides evidence for sustained vaccine efficacy, informing booster recommendations and public health policy.